# Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms

> **NCT02816944** · PHASE1,PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 80 (estimated)

## Conditions studied

- Refractory Neoplasms

## Interventions

- **PROCEDURE:** EUS-guided laser ablation for refractory neoplasms

## Key facts

- **NCT ID:** NCT02816944
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2016-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02816944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02816944, "Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02816944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*